Floatz logo

Allogeneic Cd34+-Enriched And Cd45Ra-Depleted Pbscs

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Federal Research Institute of Pediatric Hematology, Oncology and ImmunologyCell therapyPhase 1/2Dormant
CCC
50/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
37/ 100
Competitive Position
89/ 100

Competitive context

7 Active assets in the Precursor T-Cell Lymphoblastic Leukemia-Lymphoma cohort.

Asset / SponsorPhaseRating
DEXAMETHASONE
Sanofi
Phase 2B
Benadryl
Sanofi
Phase 2CCC
Venetoclax
First Affiliated Hospital of Zhejiang University
Phase 2CCC
Isatuximab
Sanofi
Phase 2CCC
RANITIDINE
Sanofi
Phase 2CCC

View all 19 →

Same molecule, other indications

Allogeneic Cd34+-Enriched And Cd45Ra-Depleted Pbscs is also rated in:

acute lymphoblastic leukemiaDormant
BBB
Indicative ·
74 / 100
View asset →
Acute Myelogenous LeukemiaDormant
BB
Indicative ·
70 / 100
View asset →
Myelodysplastic SyndromesDormant
BB
Indicative ·
68 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →